GSK and Vir Biotechnology expand coronavirus collaboration
GlaxoSmithKline plc (GSK) and Vir Biotechnology, Inc. have entered into an agreement to expand their existing collaboration to include the research and development of...
New partnership ensures dispensing between pharmacies and care homes is seamless
MED e‐care and Cegedim have announced a new partnership to integrate Cegedim’s Pharmacy Manager with MED e‐care’s electronic Medication Administration Record (eMAR). The integration of...
Positive phase III results for Lilly’s tirzepatide in type 2 diabetes
Lilly has announced positive first data from two phase III trials, showing that tirzepatide led to significant reductions in HbA1c and body weight reductions...
MHRA launches public consultation on two contraceptive pills
The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a public consultation on the reclassification of two progestogen-only contraceptive pills containing desogestrel. The consultation...
LEO Pharma appoints new Vice President
LEO Pharma has appointed Sarah Kleinpeter as Vice President of UK and Ireland, succeeding the outgoing Vice President and Managing Director Geraldine Murphy, who...
Positive phase III data for Roche’s vision loss therapy
New phase III data show Roche’s faricimab is the first investigational injectable eye medicine to extend time between treatments up to four months in...
Sandoz acquires GSK’s cephalosporin antibiotics business
Sandoz has signed an agreement to acquire GSK’s cephalosporin antibiotics business, which includes the global rights to three established brands (Zinnat®, Zinacef® and Fortum®)...
Blueprint launched for NHS reform following COVID-19 pandemic
The Health and Social Care Secretary, with the support of NHS England and health and care system leaders, will today set out new proposals...
NIHR funds study to improve the lives of people with cystic fibrosis
The NIHR has awarded funding to the University of Liverpool and Alder Hey Children’s Hospital to conduct a trial to improve the lives of...
World’s first clinical trials of COVID-19 vaccine combination
In a bid to combat future mutations of COVID-19, a joint research programme will begin in February 2021 to assess the immunogenicity and safety...
Latest articles
COVID-19 and key changes one year on
One year on from the first confirmed case of COVID-19 in the UK, Oli Hudson, Content Director at Wilmington Healthcare, takes a look at...
FDA approves Roche’s Actemra/RoActemra for interstitial lung disease
Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Actemra®/RoActemra® (tocilizumab) subcutaneous injection for slowing the rate of decline in...
Pre-clinical work completed for novel COVID-19 immunotherapy
ISA Pharmaceuticals has announced that it has completed pre-clinical work for ISA106, a novel COVID-19 immunotherapy and is planning clinical trials. A phase 1...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
NHS prescription charge to increase from 1 April 2021
The NHS prescription charge will increase to £9.35 per prescription item from 1 April 2021 in England, according to the Pharmaceutical Services Negotiating Committee...
Nasal spray to protect against COVID-19 is ready for use in humans
A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...
Pancreatic Cancer Story: James Dadge
James, 44, lives in Manchester with his partner Andrea and sons Ben and Daniel. He was diagnosed with a neuroendocrine tumour, with the primary...